Literature DB >> 16520012

Ionization, lipophilicity and solubility properties of repaglinide.

Zoran Mandić1, Vesna Gabelica.   

Abstract

Potentiometric and spectrophotometric titrations were used for the determination of ionization behaviour, lipophilicity and solubility profile of repaglinide. Acid-base equilibria were characterized by means of protonation macro- and microconstants using Target Factor Analysis of spectrophotometric data. Lipophilicity profiles were evaluated by determination of partition coefficients of neutral and ionized forms of repaglinide in biphasic octanol/water system. The intrinsic solubilities of repaglinide were determined from the solubility data and temperature dependence of intrinsic solubilities were evaluated using van't Hoff equation. Repaglinide possesses two protonation sites and in aqueous solutions exhibits ampholitic properties. At isoelectric pH the zwitterionic form of the molecule predominates over the uncharged form with the tautomeric ratio, logKz=1.9. The difference between calculated and measured logP values, as well as the difference between logP values of uncharged form of repaglinide, HR0, and either one of mono-charged forms indicated the significant partition of zwitterion into octanol. Temperature dependence of solubility data revealed exothermic dissolution process with DeltasolH=-36 kJmol-1 and negative entropy of solution of DeltasolS=-0.19 kJK-1mol-1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16520012     DOI: 10.1016/j.jpba.2006.01.056

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  16 in total

1.  Validated stability-indicating spectrofluorimetric method with enhanced sensitivity for determination of repaglinide in tablets.

Authors:  Rania N El-Shaheny
Journal:  J Fluoresc       Date:  2012-07-01       Impact factor: 2.217

Review 2.  Drug-drug and food-drug pharmacokinetic interactions with new insulinotropic agents repaglinide and nateglinide.

Authors:  André J Scheen
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

3.  Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.

Authors:  Luca Settimo; Krista Bellman; Ronald M A Knegtel
Journal:  Pharm Res       Date:  2013-11-19       Impact factor: 4.200

4.  Tautomeric and Microscopic Protonation Equilibria of Anthranilic Acid and Its Derivatives.

Authors:  Lidia Zapała; Elżbieta Woźnicka; Jan Kalembkiewicz
Journal:  J Solution Chem       Date:  2014-06-18       Impact factor: 1.677

5.  Bilayer matrix tablets for prolonged actions of metformin hydrochloride and repaglinide.

Authors:  Wei He; Shijing Huang; Chunyan Zhou; Lin Cao; Jing Yao; Jianping Zhou; Guangji Wang; Lifang Yin
Journal:  AAPS PharmSciTech       Date:  2014-10-16       Impact factor: 3.246

6.  Implications of intercorrelation between hepatic CYP3A4-CYP2C8 enzymes for the evaluation of drug-drug interactions: a case study with repaglinide.

Authors:  Kosuke Doki; Adam S Darwich; Brahim Achour; Aleksi Tornio; Janne T Backman; Amin Rostami-Hodjegan
Journal:  Br J Clin Pharmacol       Date:  2018-03-06       Impact factor: 4.335

7.  Influence of atorvastatin on the pharmacodynamic and pharmacokinetic activity of repaglinide in rats and rabbits.

Authors:  Makula Chandra Sekhar; P Jaya Chandra Reddy
Journal:  Mol Cell Biochem       Date:  2012-01-07       Impact factor: 3.396

8.  Ultra rapidly dissolving repaglinide nanosized crystals prepared via bottom-up and top-down approach: influence of food on pharmacokinetics behavior.

Authors:  Rahul Gadadare; Leenata Mandpe; Varsha Pokharkar
Journal:  AAPS PharmSciTech       Date:  2014-12-31       Impact factor: 3.246

9.  Design and evaluation of self-nanoemulsifying pellets of repaglinide.

Authors:  N S Desai; M S Nagarsenker
Journal:  AAPS PharmSciTech       Date:  2013-06-18       Impact factor: 3.246

10.  The Impact of Surfactant Composition and Surface Charge of Niosomes on the Oral Absorption of Repaglinide as a BCS II Model Drug.

Authors:  Morteza Yaghoobian; Azadeh Haeri; Noushin Bolourchian; Soraya Shahhosseni; Simin Dadashzadeh
Journal:  Int J Nanomedicine       Date:  2020-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.